- Investor's Business Daily•10 hours ago
Week in review: Fed chief Janet Yellen said the rate hike case is stronger. Mylan's EpiPen price hike outrage roiled drug stocks. Best Buy soared as dollar stores dived.
- Market Realist•16 hours ago
According to a Bloomberg consensus of 19 brokerage firms as of August 23, 2016, 94.7% of analysts recommend a "buy" for BioMarin stock.
- Capital Cube•16 hours ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Sanofi Here are 5 ETF’s with the largest exposure to SNY-US. Comparing the performance and risk of Sanofi with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name SNY-US Exposure ... Read more (Read more...)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||38.60 x 400|
|Ask||38.92 x 100|
|Day's Range||38.51 - 39.21|
|52wk Range||37.41 - 51.88|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.26|
|Avg Vol (3m)||2,327,220|
|Dividend & Yield||1.66 (4.30%)|